Health Catalyst Inc.

4.05
0.15 (3.85%)
At close: Apr 24, 2025, 11:10 AM

Health Catalyst Statistics

Share Statistics

Health Catalyst has 70.21M shares outstanding. The number of shares has increased by 18.93% in one year.

Shares Outstanding 70.21M
Shares Change (YoY) 18.93%
Shares Change (QoQ) 15.39%
Owned by Institutions (%) 85.72%
Shares Floating 66.95M
Failed to Deliver (FTD) Shares 4
FTD / Avg. Volume < 0.01%

Short Selling Information

The latest short interest is 3.12M, so 4.44% of the outstanding shares have been sold short.

Short Interest 3.12M
Short % of Shares Out 4.44%
Short % of Float 4.51%
Short Ratio (days to cover) 4.61

Valuation Ratios

The PE ratio is -6.12 and the forward PE ratio is 8.52. Health Catalyst's PEG ratio is 0.14.

PE Ratio -6.12
Forward PE 8.52
PS Ratio 1.39
Forward PS 0.6
PB Ratio 1.17
P/FCF Ratio 32.88
PEG Ratio 0.14
Financial Ratio History

Enterprise Valuation

Currently the Enterprise Value (EV) is not available for Health Catalyst.

EV / Sales n/a
EV / EBITDA n/a
EV / EBIT n/a
EV / FCF n/a

Financial Position

The company has a current ratio of 1.43, with a Debt / Equity ratio of 0.69.

Current Ratio 1.43
Quick Ratio 1.43
Debt / Equity 0.69
Debt / EBITDA -9.26
Debt / FCF 19.4
Interest Coverage -109.59

Financial Efficiency

Return on Equity is n/a and Return on Invested Capital is n/a.

Return on Equity n/a
Return on Assets n/a
Return on Invested Capital n/a
Revenue Per Employee $204.39K
Profits Per Employee $-46.33K
Employee Count 1,500
Asset Turnover 0.36
Inventory Turnover n/a

Taxes

Income Tax 333K
Effective Tax Rate -0.48%

Stock Price Statistics

The stock price has increased by -34.99% in the last 52 weeks. The beta is 1.44, so Health Catalyst's price volatility has been higher than the market average.

Beta 1.44
52-Week Price Change -34.99%
50-Day Moving Average 4.45
200-Day Moving Average 6.64
Relative Strength Index (RSI) 44.25
Average Volume (20 Days) 762.54K

Income Statement

In the last 12 months, Health Catalyst had revenue of 306.58M and earned -69.5M in profits. Earnings per share was -1.15.

Revenue 306.58M
Gross Profit 140.78M
Operating Income -69.81M
Net Income -69.5M
EBITDA -27.1M
EBIT -68.53M
Earnings Per Share (EPS) -1.15
Full Income Statement

Balance Sheet

The company has 249.65M in cash and 251.09M in debt, giving a net cash position of -1.44M.

Cash & Cash Equivalents 249.65M
Total Debt 251.09M
Net Cash -1.44M
Retained Earnings -1.19B
Total Assets 858.93M
Working Capital 139.8M
Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was 14.56M and capital expenditures -1.62M, giving a free cash flow of 12.94M.

Operating Cash Flow 14.56M
Capital Expenditures -1.62M
Free Cash Flow 12.94M
FCF Per Share 0.22
Full Cash Flow Statement

Margins

Gross margin is 45.92%, with operating and profit margins of -22.77% and -22.67%.

Gross Margin 45.92%
Operating Margin -22.77%
Pretax Margin -22.56%
Profit Margin -22.67%
EBITDA Margin -8.84%
EBIT Margin -22.77%
FCF Margin 4.22%

Dividends & Yields

HCAT does not appear to pay any dividends at this time.

Dividend Per Share n/a
Dividend Yield n/a
Dividend Growth (YoY) n/a
Payout Ratio n/a
Earnings Yield n/a
FCF Yield n/a
Dividend Details

Analyst Forecast

The average price target for HCAT is $8, which is 104.1% higher than the current price. The consensus rating is "Buy".

Price Target $8
Price Target Difference 104.1%
Analyst Consensus Buy
Analyst Count 11
Stock Forecasts

Scores

Altman Z-Score -1.34
Piotroski F-Score 4